The polyneuropathy associated with Waldenström's macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximab
- 1 June 2000
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 109 (4) , 838-841
- https://doi.org/10.1046/j.1365-2141.2000.02086.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Induction of Complete Haematological Remission After Monotherapy with AntLCD20 Monoclonal Antibody (RITUXIMAB) in a Patient with Alkylating Agent Resistant Waldenstrom's MacroglobulinaemiaLeukemia & Lymphoma, 1999
- Lymphoproliferative disorders and motor neuron diseaseNeurology, 1997
- POEMS syndrome and Waldenstrom's macroglobulinaemia.Journal of Clinical Pathology, 1996
- Waldenstrom's macroglobulinemiaBlood, 1994
- Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathiesJournal of the Neurological Sciences, 1993
- Peripheral neuropathies associated with monoclonal proteinsMedical Clinics of North America, 1993
- Complement-Mediated Demyelination in Patients with IgM Monoclonal Gammopathy and PolyneuropathyNew England Journal of Medicine, 1990
- Polyneuropathies Associated With IgM Monoclonal GammopathiesArchives of Neurology, 1988
- Polyneuropathy in Waldenström s macroglobulinaemia. Passive transfer from man to mouseActa Neurologica Scandinavica, 1987